Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Anna Chalmers"'
Autor:
Dena R Howard, Talha Munir, Lucy McParland, Andy C Rawstron, Anna Chalmers, Walter M Gregory, John L O’Dwyer, Alison Smith, Roberta Longo, Abraham Varghese, Alexandra Smith, Peter Hillmen
Publikováno v:
Health Technology Assessment, Vol 21, Iss 28 (2017)
Background: The conventional frontline therapy for fit patients with chronic lymphocytic leukaemia (CLL) is fludarabine, cyclophosphamide and rituximab (FCR). Rituximab (Mabthera®, Roche Products Ltd) targets the CD20 antigen, which is expressed at
Externí odkaz:
https://doaj.org/article/03938ff7492b4c218f74b239ad351a68
Autor:
Christopher Parrish, Jenny Bird, John Ashcroft, John A. Snowden, Julia Brown, Curly Morris, Cathy D. Williams, Jim Cavet, David A Cairns, Hannah Hunter, Kwee Yong, Jamie Cavenagh, Gordon Cook, Steve Schey, Anna Chalmers, Sally Chown
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:1009-1016
The phase III British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X trial (MMX) demonstrated prospectively, for the first time, superiority of salvage autologous stem cell transplantation over chemotherapy mainten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5ed9a9b5b4116aa6eed8ccd961564c
https://doi.org/10.1016/j.bbmt.2016.01.016
https://doi.org/10.1016/j.bbmt.2016.01.016
Autor:
Charlotte Pawlyn, Alina Striha, Mark T. Drayson, de, Tute, Rm, John R Jones, Walter M Gregory, David A Cairns, Andy C. Rawstron, Martin Kaiser, Graham Jackson, G. J. Morgan, Faith E. Davies, Anna Chalmers, Graham P. Cook, Roger G. Owen, Corinne Collett, Nigel H. Russell
Publikováno v:
British Journal of Haematology. 173:5-178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::359eced9a3247579733acd3b99fe78f8
https://doi.org/10.1111/bjh.14019
https://doi.org/10.1111/bjh.14019
Autor:
Alexandra Smith, Abraham M. Varghese, Lucy McParland, Walter M Gregory, Dena R. Howard, Alison Smith, Roberta Longo, Peter Hillmen, John O’Dwyer, Anna Chalmers, Andy C. Rawstron, Talha Munir
Publikováno v:
Health Technology Assessment, Vol 21, Iss 28 (2017)
BackgroundThe conventional frontline therapy for fit patients with chronic lymphocytic leukaemia (CLL) is fludarabine, cyclophosphamide and rituximab (FCR). Rituximab (Mabthera®, Roche Products Ltd) targets the CD20 antigen, which is expressed at lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d90026aa65ea2e9f85b5086f2ab62fa1
https://eprints.whiterose.ac.uk/88372/10/3010498.pdf
https://eprints.whiterose.ac.uk/88372/10/3010498.pdf
Autor:
David A Cairns, Treen C. M. Morris, Jenny Bird, John A. Snowden, Kwee Yong, Gordon Cook, Cathy D. Williams, Julia Brown, Marie Fletcher, Jim Cavet, Hanna Hunter, Anna Chalmers, Christopher Parrish, Jamie Cavenagh, A John Ashcroft, Sheila J.M. O’Connor, Mark T. Drayson
Publikováno v:
The Lancet Oncology. 15:874-885
Summary Background Relapsed multiple myeloma has no standard treatment, and the role of autologous stem-cell transplantation (ASCT) has not been fully defined. We aimed to compare high-dose melphalan plus salvage ASCT with cyclophosphamide in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f43fdb4e1c004bc9fbad791d73454ab
https://doi.org/10.1016/s1470-2045(14)70245-1
https://doi.org/10.1016/s1470-2045(14)70245-1
Autor:
Anna Chalmers, Ronald Fischer
Publikováno v:
Personality and Individual Differences. 45:378-382
A meta-analysis of dispositional optimism levels as measured by the life orientation test (LOT, Scheier & Carver, 1985 ) across 22 countries (k = 213; N = 89,138) is reported. Using mixed effect modeling, overall culture differences were small. Great
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::147d0a9543ada0ec1583b3506237ea24
https://doi.org/10.1016/j.paid.2008.05.008
https://doi.org/10.1016/j.paid.2008.05.008
Autor:
Corinne Collett, Walter M Gregory, Donald Milligan, Tahla Munir, Abraham M. Varghese, David Allsup, Alexander Smith, Andy C. Rawstron, Lucy McParland, Anna Schuh, Andrew S Duncombe, Peter Hillmen, Scott Marshall, Anna Chalmers, Dena Cohen
Publikováno v:
BRITISH JOURNAL OF HAEMATOLOGY. 165
Introduction FCR improves PFS and OS in CLL. Previous non-randomised Phase II trials suggest adding mitoxantrone to FCR (FCM-R) improves outcomes. The rituximab dose in CLL was inferred from lymphoma but in CLL even low doses of rituximab lead to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c4cf599e9215c90f589e320fd1475c6
http://ora.ox.ac.uk/objects/uuid:2ab60540-bb4d-44e0-830b-8a1d33e68e6c
http://ora.ox.ac.uk/objects/uuid:2ab60540-bb4d-44e0-830b-8a1d33e68e6c
Autor:
Ruth M. de Tute, Peter Hillmen, Kristian Brock, Andy C. Rawstron, Samuel Muñoz-Vicente, Walter M Gregory, Francesca Yates, Anna Chalmers, Laura Collett, Abraham M. Varghese, Rebecca Bishop, David Phillips, Lucy McParland, Talha Munir, Dena R. Howard
Publikováno v:
Blood. 128:3226-3226
Background: The detection of minimal residual disease (MRD) in CLL using a 0.01% cut-off is an independent predictor of progression-free (PFS) and overall survival (OS) after chemo-immunotherapy. There are several new treatments available and using M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d59ad5b8b6ad8911565847d88690196
https://doi.org/10.1182/blood.v128.22.3226.3226
https://doi.org/10.1182/blood.v128.22.3226.3226
Autor:
Anna Chalmers
Publikováno v:
Alexandria: The Journal of National and International Library and Information Issues. 9:101-113
In 1996 the national libraries of Australia, Canada, France, Germany, Ireland, Malaysia, the Netherlands, New Zealand, Singapore, the UK and the USA took part in a study of their experiences with strategic management. A literature review had identifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a3127067838e03953ef1476bab072a5
https://doi.org/10.1177/095574909700900202
https://doi.org/10.1177/095574909700900202
Autor:
Anna Chalmers, Peter Hernon
Publikováno v:
Government Information Quarterly. 14:65-90
This article, which reports the results of a recent survey, assesses the Scheme's role, value, strengths, weaknesses, challenges, and opportunities at a time when the New Zealand government is embracing the electronic provision of government informat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1c65ff1f58a6f868948331b87b09ca0
https://doi.org/10.1016/s0740-624x(97)90052-6
https://doi.org/10.1016/s0740-624x(97)90052-6